Institute: IDIBELL
PI: Oscar Martinez-Tirado
Project: Alveolar rhabdomyosarcoma is a rare childhood tumor. In this project we aim to identify new possibilities for short circuiting cancer metabolism, based on the genotype of these tumors, which may lead to novel drug combinations.
Expected Results: To identify metabolic factors and pathways important for fusion protein-associated pediatric sarcomas progression.
As part of our MSCA-ESR training on complementary skills we got to leave the wet lab to explore what happens on the other side of the bench and to learn what it means to be a scientific editor. This is our story.
The new work developed in the lab of META-CAN’s coordinator, Cristina Muñoz-Pinedo, has finally seen the light in a paper at PNAS. The study has been possible thanks to an amazing group of researchers and the funding of two MSCA Actions: TRAINERS (GA 675448) and META-CAN (GA 766214).
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766214.
Bellvitge Biomedical
Research Institute (IDIBELL)
Hospital Duran i Reynals, 3a planta
Gran Via de l’Hospitalet, 199
08908 L’Hospitalet del Llobregat
Barcelona, Spain
